SCHEMBL31207445

SCHEMBL31207445

Nc1cc(Cl)c(-c2ccc(OC3CCS(=O)(=O)CC3)nc2)cc1F

nearest known ligand 0.45

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
FEN1 P39748 6/20 0.45
TDO2 P48775 3/20 0.40
PAICS P22234 2/20 0.38
ALOX5AP P20292 3/20 0.37
DGAT1 O75907 4/20 0.37
CACNB4 O00305 1/20 0.36
CACNA1A O00555 1/20 0.36
CACNA1G O43497 1/20 0.36
CACNG3 O60359 1/20 0.36
CACNA1F O60840 1/20 0.36
CACNA1H O95180 1/20 0.36
CACNB3 P54284 1/20 0.36
CACNA2D1 P54289 1/20 0.36
CACNG7 P62955 1/20 0.36
CACNA1B Q00975 1/20 0.36
CACNA1D Q01668 1/20 0.36
CACNB1 Q02641 1/20 0.36
CACNG1 Q06432 1/20 0.36
CACNB2 Q08289 1/20 0.36
CACNA1S Q13698 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL30296663 0.90 TDO2 (0.45) FEN1TDO2PAICSALOX5APDGAT1
SCHEMBL26461154 0.88 TDO2 (0.43) FEN1TDO2PAICSALOX5APDGAT1
SCHEMBL30296462 0.88 TDO2 (0.43) FEN1TDO2PAICSALOX5APDGAT1
SCHEMBL30296607 0.88 TDO2 (0.43) FEN1TDO2PAICSALOX5APDGAT1
SCHEMBL30296565 0.85 TDO2 (0.41) FEN1TDO2PAICSALOX5APDGAT1
SCHEMBL31207378 0.85 ALOX5AP (0.45) FEN1TDO2PAICSALOX5APDGAT1
SCHEMBL30296242 0.82 TDO2 (0.38) FEN1TDO2PAICSALOX5APDGAT1
SCHEMBL30296497 0.82 TDO2 (0.38) FEN1TDO2PAICSALOX5APDGAT1
SCHEMBL26459805 0.82 TDO2 (0.38) FEN1TDO2PAICSALOX5APDGAT1
SCHEMBL26459487 0.82 TDO2 (0.38) FEN1TDO2PAICSALOX5APDGAT1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4702021-A1 COMPOUNDS CAPABLE OF MODULATING GPR65 Pathios Therapeutics Limited (GB) 2026-03-04 EP disclosed
WO-2024224064-A1 COMPOUNDS CAPABLE OF MODULATING GPR65 Pathios Therapeutics Limited (GB) 2024-10-31 WO disclosed